Insulet Quick Ratio 2010-2025 | PODD
Historical quick ratio values for Insulet (PODD) over the last 10 years.
| Insulet Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2025-03-31 | $1.89B | $0.52B | 3.63 |
| 2024-12-31 | $1.46B | $0.53B | 2.77 |
| 2024-09-30 | $1.42B | $0.51B | 2.80 |
| 2024-06-30 | $1.32B | $0.49B | 2.71 |
| 2024-03-31 | $1.19B | $0.43B | 2.75 |
| 2023-12-31 | $1.18B | $0.45B | 2.62 |
| 2023-09-30 | $1.06B | $0.45B | 2.35 |
| 2023-06-30 | $1.01B | $0.43B | 2.38 |
| 2023-03-31 | $0.94B | $0.38B | 2.46 |
| 2022-12-31 | $0.97B | $0.37B | 2.65 |
| 2022-09-30 | $1.00B | $0.33B | 3.00 |
| 2022-06-30 | $0.99B | $0.28B | 3.54 |
| 2022-03-31 | $0.97B | $0.22B | 4.51 |
| 2021-12-31 | $1.03B | $0.23B | 4.49 |
| 2021-09-30 | $1.05B | $0.23B | 4.58 |
| 2021-06-30 | $1.06B | $0.21B | 4.95 |
| 2021-03-31 | $1.02B | $0.19B | 5.51 |
| 2020-12-31 | $1.09B | $0.21B | 5.27 |
| 2020-09-30 | $1.04B | $0.18B | 5.91 |
| 2020-06-30 | $0.98B | $0.13B | 7.31 |
| 2020-03-31 | $0.45B | $0.13B | 3.42 |
| 2019-12-31 | $0.49B | $0.16B | 3.11 |
| 2019-09-30 | $0.70B | $0.11B | 6.21 |
| 2019-06-30 | $0.41B | $0.11B | 3.91 |
| 2019-03-31 | $0.42B | $0.11B | 3.71 |
| 2018-12-31 | $0.39B | $0.12B | 3.37 |
| 2018-09-30 | $0.39B | $0.10B | 3.99 |
| 2018-06-30 | $0.38B | $0.08B | 5.01 |
| 2018-03-31 | $0.43B | $0.08B | 5.16 |
| 2017-12-31 | $0.50B | $0.09B | 5.85 |
| 2017-09-30 | $0.33B | $0.08B | 4.42 |
| 2017-06-30 | $0.31B | $0.05B | 6.35 |
| 2017-03-31 | $0.30B | $0.04B | 7.69 |
| 2016-12-31 | $0.33B | $0.06B | 6.01 |
| 2016-09-30 | $0.33B | $0.05B | 6.07 |
| 2016-06-30 | $0.16B | $0.06B | 2.84 |
| 2016-03-31 | $0.16B | $0.05B | 3.17 |
| 2015-12-31 | $0.18B | $0.07B | 2.74 |
| 2015-09-30 | $0.18B | $0.06B | 3.05 |
| 2015-06-30 | $0.18B | $0.05B | 3.42 |
| 2015-03-31 | $0.19B | $0.05B | 3.91 |
| 2014-12-31 | $0.20B | $0.04B | 4.40 |
| 2014-09-30 | $0.20B | $0.05B | 4.12 |
| 2014-06-30 | $0.22B | $0.07B | 3.13 |
| 2014-03-31 | $0.19B | $0.04B | 4.39 |
| 2013-12-31 | $0.19B | $0.04B | 4.45 |
| 2013-09-30 | $0.19B | $0.05B | 4.02 |
| 2013-06-30 | $0.19B | $0.03B | 5.65 |
| 2013-03-31 | $0.19B | $0.04B | 4.32 |
| 2012-12-31 | $0.10B | $0.05B | 1.97 |
| 2012-09-30 | $0.10B | $0.05B | 2.01 |
| 2012-06-30 | $0.10B | $0.04B | 2.32 |
| 2012-03-31 | $0.11B | $0.03B | 3.48 |
| 2011-12-31 | $0.12B | $0.03B | 4.32 |
| 2011-09-30 | $0.13B | $0.03B | 5.04 |
| 2011-06-30 | $0.13B | $0.03B | 4.96 |
| 2011-03-31 | $0.12B | $0.02B | 7.22 |
| 2010-12-31 | $0.13B | $0.02B | 6.91 |
| 2010-09-30 | $0.12B | $0.02B | 5.89 |
| 2010-06-30 | $0.14B | $0.02B | 5.70 |
| 2010-03-31 | $0.14B | $0.02B | 7.56 |
| 2009-12-31 | $0.14B | $0.02B | 7.28 |
| 2009-09-30 | $0.09B | $0.02B | 4.97 |
| 2009-06-30 | $0.07B | $0.02B | 4.17 |
| 2009-03-31 | $0.09B | $0.02B | 4.29 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $19.948B | $2.072B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $209.668B | 24.59 |
| Boston Scientific (BSX) | United States | $154.824B | 38.76 |
| Stryker (SYK) | United States | $148.439B | 31.04 |
| EssilorLuxottica (ESLOY) | France | $131.494B | 0.00 |
| Medtronic (MDT) | Ireland | $114.826B | 16.28 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.743B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.081B | 24.59 |
| ResMed (RMD) | United States | $37.598B | 28.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.909B | 16.57 |
| Agilent Technologies (A) | United States | $33.054B | 21.55 |
| Terumo (TRUMY) | Japan | $24.345B | 31.62 |
| Koninklijke Philips (PHG) | Netherlands | $23.697B | 16.63 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.776B | 12.06 |
| Baxter (BAX) | United States | $14.312B | 10.69 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.087B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.794B | 23.64 |
| Lantheus Holdings (LNTH) | United States | $5.092B | 12.85 |
| Perrigo (PRGO) | Ireland | $3.733B | 9.46 |
| Prestige Consumer Healthcare (PBH) | United States | $3.713B | 16.58 |
| Haemonetics (HAE) | United States | $3.529B | 16.07 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.347B | 27.82 |
| ICU Medical (ICUI) | United States | $3.070B | 22.64 |
| LeMaitre Vascular (LMAT) | United States | $1.855B | 41.47 |
| QuidelOrtho (QDEL) | United States | $1.804B | 12.41 |
| AtriCure (ATRC) | United States | $1.473B | 0.00 |
| Acuren (TIC) | United States | $1.444B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.242B | 12.60 |
| Green Thumb Industries (GTBIF) | United States | $1.207B | 27.14 |
| Phibro Animal Health (PAHC) | United States | $1.205B | 15.40 |
| Neogen (NEOG) | United States | $1.055B | 13.50 |
| BioLife Solutions (BLFS) | United States | $1.025B | 0.00 |
| InMode (INMD) | Israel | $0.891B | 8.98 |
| Kestra Medical Technologies (KMTS) | United States | $0.845B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.674B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.639B | 0.00 |
| Owens & Minor (OMI) | United States | $0.617B | 5.12 |
| Tilray Brands (TLRY) | Canada | $0.615B | 0.00 |
| Evolus (EOLS) | United States | $0.602B | 0.00 |
| CeriBell (CBLL) | United States | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.553B | 0.00 |
| Surmodics (SRDX) | United States | $0.438B | 0.00 |
| SNDL (SNDL) | Canada | $0.410B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.327B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.323B | 11.89 |
| Sanuwave Health (SNWV) | United States | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.23 |
| Cerus (CERS) | United States | $0.262B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 75.83 |
| OraSure Technologies (OSUR) | United States | $0.245B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.244B | 0.00 |
| ZimVie (ZIMV) | United States | $0.241B | 10.96 |
| Biote (BTMD) | United States | $0.228B | 6.42 |
| Brainsway (BWAY) | Israel | $0.219B | 58.05 |
| Verano Holdings (VRNOF) | United States | $0.204B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.204B | 0.00 |
| Omeros (OMER) | United States | $0.204B | 0.00 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Organigram Global (OGI) | Canada | $0.196B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.82 |
| TriSalus Life Sciences (TLSI) | United States | $0.179B | 0.00 |
| Exagen (XGN) | United States | $0.153B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 15.33 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| Jin Medical (ZJYL) | China | $0.101B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.74 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.071B | 0.00 | |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.052B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 14.54 |
| Nephros (NEPH) | United States | $0.038B | 51.14 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |